Extracorporeal hemocorrection in complex therapy of septic shock in children

Aleksandrovich Yu.S.; Serednyakov K.V.; Pshenisnov K.V.

doi:https://doi.org/10.17116/anaesthesiology2021041110

Aleksandrovich Yu.S.

Children’s Scientific Clinical Center for Infectious Diseases

ORCID: 0000-0002-2131-4813

Serednyakov K.V.

Children’s Research and Clinical Center for Infectious Diseases of the FMBA of Russia;
St. Petersburg State Pediatric Medical University

Pshenisnov K.V.

Children’s Scientific Clinical Center for Infectious Diseases

ORCID: 0000-0003-1113-5296

Extracorporeal hemocorrection in complex therapy of septic shock in children

Authors:

Aleksandrovich Yu.S., Serednyakov K.V., Pshenisnov K.V.

More about the authors

Journal: Russian Journal of Anesthesiology and Reanimatology. 2021;(4): 110‑117

DOI: 10.17116/anaesthesiology2021041110

Read: 2667 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Aleksandrovich YuS, Serednyakov KV, Pshenisnov KV. Extracorporeal hemocorrection in complex therapy of septic shock in children. Russian Journal of Anesthesiology and Reanimatology. 2021;(4):110‑117. (In Russ.)
https://doi.org/10.17116/anaesthesiology2021041110

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To assess an effectiveness of extracorporeal hemocorrection (EH) in therapy of septic shock in children.

MATERIAL AND METHODS

A multiple-center observational uncontrolled study included 62 children aged 5 (2-13) years. Depending on timing and technique of EH, all patients were divided into 3 groups: group I — EH only for signs of acute kidney injury (AKI); group II — EH before AKI or for renal damage grade 1. In both these groups, only continuous veno-venous hemodiafiltration (CVVHDF) was used. In group III, EH was started immediately after diagnosis of septic shock, CVVHDF was combined with polymyxin B hemoperfusion. Cardiac index (CI), endotoxin activity assay (EAA), neutrophil phagocytic activity, vasoactive Inotrope Score (VIS), duration of mechanical ventilation and incidence of acute kidney injury were evaluated to assess effectiveness of therapy.

RESULTS

Significant decrease of VIS compared to baseline value was noted in groups II (by 18.75%) and III (by 43.74%). In group III, we found significant increase of CI (from 3.1 to 4.0L/min/m²; p<0.05). In the same group, EAA reduction from 0.69 to 0.52 was detected a day after surgery (p<0.01). Moreover, we observed increase of phagocytic activity of neutrophils (from 0.56 to 0.6; p<0.05). Among survivors in all groups, restoration of kidney function was observed in 89.9% of cases. Incidence of terminal AKI followed by hemodialysis was 11.1%. In-hospital mortality was minimal in the third group.

CONCLUSION

Early EH (CVVHDF combined with polymyxin B hemoperfusion) reduces ICU stay and improves the outcomes in children with septic shock.

Keywords:

generalized fulminant meningococcal infection

sepsis

septic shock

extracorporeal hemocorrection

polymyxin B hemoperfusion (PMX hemoperfusion)

children

outcome

Authors:

Aleksandrovich Yu.S.

Children’s Scientific Clinical Center for Infectious Diseases

ORCID: 0000-0002-2131-4813

Serednyakov K.V.

Children’s Research and Clinical Center for Infectious Diseases of the FMBA of Russia;
St. Petersburg State Pediatric Medical University

Pshenisnov K.V.

Children’s Scientific Clinical Center for Infectious Diseases

ORCID: 0000-0003-1113-5296

Received:

11.01.2021

Accepted:

23.04.2021

Close metadata

References:

Aleksandrovich YuS, Ivanov DO, Pshenisnov KV. Sepsis novorozhdennykh. Posobie dlya vrachej. SPb: Izd-vo SPbGPMU; 2019. (In Russ.).
Balamuth F, Weiss SL, Neuman MI, Scott H, Brady PW, Paul R, Farris RW, McClead R, Hayes K, Gaieski D, Hall M, Shah SS, Alpern ER. Pediatric severe sepsis in U.S. children’s hospitals. Pediatr Crit Care Med. 2014;15(9):798-805. https://doi.org/10.1097/PCC.0000000000000225
Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. The Lancet. Respiratory Medicine. 2018;6(3):223-230. https://doi.org/10.1016/S2213-2600(18)30063-8
Iwagami M, Yasunaga H, Noiri E, Horiguchi H, Fushimi K, Matsubara T, Yahagi N, Nangaku M, Doi K. Potential survival benefit of polymyxin B hemoperfusion in septic shock patients on continuous renal replacement therapy: a propensity-matched analysis. Blood Purification. 2016;42(1):9-17. https://doi.org/10.1159/000444474
Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, Palevsky PM, Weisberg LS, Schorr CA, Trzeciak S, Walker PM; EUPHRATES Trial Investigators. Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA. 2018;320(14):1455-1463. https://doi.org/0.1001/jama.2018.14618
Riley AA, Watson M, Smith C, Guffey D, Minard CG, Currier H, Akcan Arikan A. Pediatric continuous renal replacement therapy: have practice changes changed outcomes? A large single-center ten-year retrospective evaluation. BMC Nephrology. 2018;19(1):268. https://doi.org/10.1186/s12882-018-1068-1
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Medicine. 2017;43(3):304-377. https://doi.org/10.1007/s00134-017-4683-6
Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, Nadel S, Schlapbach LJ, Tasker RC, Argent AC, Brierley J, Carcillo J, Carrol ED, Carroll CL, Cheifetz IM, Choong K, Cies JJ, Cruz AT, De Luca D, Deep A, Faust SN, De Oliveira CF, Hall MW, Ishimine P, Javouhey E, Joosten KFM, Joshi P, Karam O, Kneyber MCJ, Lemson J, MacLaren G, Mehta NM, Møller MH, Newth CJL, Nguyen TC, Nishisaki A, Nunnally ME, Parker MM, Paul RM, Randolph AG, Ranjit S, Romer LH, Scott HF, Tume LN, Verger JT, Williams EA, Wolf J, Wong HR, Zimmerman JJ, Kissoon N, Tissieres P. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Medicine. 2020;46(Suppl 1):10-67. https://doi.org/10.1007/s00134-019-05878-6
Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, Pottecher J, Joannes-Boyau O, Martin-Lefevre L, Jabaudon M, Mimoz O, Coudroy R, Ferrandière M, Kipnis E, Vela C, Chevallier S, Mallat J, Robert R; ABDOMIX Group. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Medicine. 2015;41(6):975-984. https://doi.org/10.1007/s00134-015-3751-z
Lobzin YuV, Muzurov AL, Serednyakov KV, Popa AV, Kvaracheliya MV, Abaseeva TYu, Pankratenko TE. Sorption and dialysis technologies of extracorporeal blood purification in pediatric intensive care. Anesteziologiya i Reanimatologiya. 2020;5:56-62. (In Russ.). https://doi.org/10.17116/anaesthesiology202005156
Lobzin YuV, Skripchenko NV, Serednjakov KV, Markova KV. Sposob lecheniya generalizovannoj formy meningokokkovoj infektsii u detej s refrakternym septicheskim shokom i sindromom poliorgannoj nedostatochnosti. Patent RF na izobretenie №RU 2712050 C1/24.01.20. Byull. №3. (In Russ.). Accessed January 05, 2021. https://elibrary.ru/item.asp?id=42447834
Yarustovsky MB, Abramyan MV, Soldatkina AO, Komardina EV, Nazarova EI, Plyushch MG, Rogalskaya EA. Preliminary report regarding the use of lps-adsorption in complex intensive therapy for children with gram-negative sepsis after heart surgery. Anesteziologiya i Reanimatologiya. 2017;62(5): 376-381. (In Russ.). Accessed January 05, 2021. https://www.medlit.ru/journalsview/anestezioreanim/view/journal/en/2017/issue-5/1206-preliminary-report-regarding-the-use-of-lps-adsorption-in-complex-intensive-therapy-for-children-with-gram-negative-sepsis-after-heart-surgery
Yarustovskiy MB, Abramyan MV, Rogalskaya EA, Komardina EV. Selective polymyxin hemoperfusion in complex therapy of sepsis in children after cardiac surgery. Blood Purification. 2021;50(2):222-229. https://doi.org/10.1159/000510126
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8): 801-810. https://doi.org/10.1001/jama.2016.0287
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements. 2012;2(1):1-138.
Yarustovsky MB, Samsonova NN, Rogalskaya EA, Klimovich LG, Plyushch MG, Abramyan MV, Krotenko NP, Niyazmatov AA. Express diagnostics of endotoxaemia during postoperative period in cardiac surgical patients. Anesteziologiya i Reanimatologiya. 2013;3:25-29. (In Russ.).
Romaschin AD, Harris DM, Ribeiro MB, Paice J, Foster DM, Walker PM, Marshall JC. A rapid assay of endotoxin in whole blood using autologous neutrophil dependent chemiluminescence. Journal of Immunological Methods. 1998;212(2):169-185. https://doi.org/10.1016/s0022-1759(98)00003-9
McIntosh AM, Tong S, Deakyne SJ, Davidson JA, Scott HF. Validation of the vasoactive-inotropic score in pediatric sepsis. Pediatr Crit Care Med. 2017;18(8):750-757. https://doi.org/10.1097/PCC.0000000000001191
Drapkina OM, Dzhioeva ON. Modern echocardiographic criteria for heart failure with preserved ejection fraction: not only diastolic dysfunction. Kardiovaskulyarnaya terapiya i profilaktika, 2020;19(2):66-74. (In Russ.). https://doi.org/10.15829/1728-8800-2020-2454
Ishibe Y, Shibata S, Takahashi G, Suzuki Y, Inoue Y, Endo S. Association of type II secretory phospholipase A2 and surfactant protein D with the pulmonary oxygenation potential in patients with septic shock during polymyxin-B immobilized fiber-direct hemoperfusion. Journal of Clinical Apheresis. 2017;32(5):302-310. https://doi.org/10.1002/jca.21507